Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.
Nephrology (Carlton). 2013 Feb;18(2):148-56. doi: 10.1111/nep.12009.
Haemoglobin (Hb) variability is associated with poor survival in patients with chronic kidney disease. Association of Hb variability after kidney transplantation with patients' and graft survival has not been adequetly studied.
This retrospective study used registry data to examine the association between Hb variability in the early post-transplant period (first 6 months) and graft survival after kidney transplantatin. Kaplan-Meier and Cox regression analyses were used for univariate and multivariate associations between mortality, death censored graft survival and the composite outcome of both, in 752 patients after kidney transplantation. Hb values were collected each month during the first 6 months after transplantation, and Hb variavility was calculated using the residual standard deviation method.
The highest quartile of Hb variability was associated with inferior graft and patients' survival in univariate (hazard ratio (HR) 2.18; 95% confidence interval (CI) 1.51 to 3.13; P < 0.001) and multivariate models (HR 1.5; 95% CI 1.029 to 2.18; P = 0.035). This association was mainly due to increased death censored graft failure in the high variability group (HR 2.75; 95% CI 1.73 to 4.38; P < 0.001) and (HR 1.67; 95% CI 1.023 to 2.74; P = 0.04) in the univariate and multivariate models, respectively. There was no association between Hb variability and the risk of death (HR 1.51; 95% CI 0.88 to 2.57; P = 0.132).
High Hb variability is independently associated with inferior graft survival in patients after kidney transplantation.
血红蛋白(Hb)变异性与慢性肾脏病患者的预后不良相关。肾移植后 Hb 变异性与患者和移植物存活率之间的关系尚未得到充分研究。
本回顾性研究使用登记数据来检查移植后早期(前 6 个月)Hb 变异性与肾移植后移植物存活率之间的关系。Kaplan-Meier 和 Cox 回归分析用于 752 例肾移植患者的死亡率、死亡相关移植物存活率和两者复合结局之间的单变量和多变量关联。在移植后第一个 6 个月期间,每月收集 Hb 值,并使用残差标准差法计算 Hb 变异性。
在单变量(风险比 (HR) 2.18;95%置信区间 (CI) 1.51 至 3.13;P<0.001)和多变量模型(HR 1.5;95%CI 1.029 至 2.18;P=0.035)中,Hb 变异性最高四分位数与移植物和患者存活率降低相关。这种相关性主要归因于高变异性组死亡相关移植物失败的增加(HR 2.75;95%CI 1.73 至 4.38;P<0.001)和(HR 1.67;95%CI 1.023 至 2.74;P=0.04)在单变量和多变量模型中分别。Hb 变异性与死亡风险之间没有关联(HR 1.51;95%CI 0.88 至 2.57;P=0.132)。
肾移植后患者 Hb 变异性高与移植物存活率降低独立相关。